Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    Open Studies | "Cholangitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Necessity of Bile Cultures in Patients With Acute Cholangitis
Condition: Acute Cholangitis
Intervention: Other: Ignoring result of bile culture
2 Not yet recruiting Quality of Life in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Other: quality of life survey
3 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
4 Recruiting PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Cenicriviroc 150 mg
5 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA)
6 Recruiting A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: BTT1023
7 Recruiting Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis
Condition: Primary Biliary Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
8 Not yet recruiting A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: hymecromone
9 Recruiting Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Mitomycin C;   Drug: Normal saline
10 Recruiting Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Vancomycin;   Drug: Placebo
11 Not yet recruiting A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Curcumin
12 Recruiting Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Biological: NGM282;   Other: Placebo
13 Recruiting Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
14 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
15 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
Intervention:
16 Recruiting Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Conditions: IgG4-related Sclerosing Cholangitis;   IgG4-related Disease
Intervention:
17 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
18 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
19 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
20 Recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.